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ABSTRACT
￿
The effect of epidermal growth factor (EGF) on gastric acid secretion was correlated
with the morphological changes of the apical pole of rat parietal cells studied by transmission
electron microscopy .
Gastric acid secretion was stimulated by histamine, carbachol, pentagastrin, and insulin-
induced hypoglycemia, and estimated by continuous recording of pH variations of gastric
luminal perfusate. EGF inhibits acid secretion in these conditions .
The action of the hormone also results in the arrest or reversal of the changes in shape
undergone by parietal cells as they go into secretion.
In view of the evidence involving cytoskeletal elements in the generation of these structural
alterations, our observations suggest that the action of EGF on gastric acid secretion may be a
consequence of a general effect of this hormone on cytoskeletal function .
Early effects produced by epidermal growth factor (EGF)
include induction of changes in morphology ofhuman epithe-
lioid carcinoma cells in culture (8), stimulation of endocytosis
(14), and enhancement of mobility of concanavalinA receptors
in the plasma membrane of 3T3 cells (1) . All these phenomena
are known to involve the Cytoskeleton .
Alongside these effects, it is interesting to note thatEGF has
been reported to inhibit gastric acid secretion (4, 12) and to be
nearly indentical to urogastrone, a hormone for which a role in
the regulation of hydrochloric acid secretion has been claimed
(13) . It appears of interest to establish whether this particular
effect can be related to other known actions of EGF .
Previous work has shown that oxyntic cells undergo impor-
tant changes in shape during acid secretion (17, 28), and we
have presented evidence indicating that these changes are
related to interactions between cytoskeletal elements and the
plasma membrane (26, 27) .
In this report, we show thatEGF rapidly inhibits gastric acid
secretion elicited in the rat by a variety of secretagogues and
that this inhibition is accompanied by early and extensive
changes in the morphology of the apical pole of parietal cells.
These results constitute additional evidence for an effect ofthis
hormone on cytoskeletal function and indicate that the inhi-
bition of acid secretion may well be a manifestation of such an
effect .
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MATERIALS AND METHODS
Materials
Mouse EGF was purchased from Collaborative Research Inc ., Waltham,
Mass. Pentagastrin was obtained from Ayerst Laboratories Inc ., New York.
Crystalline insulin was from Novo Industri A/S, Copenhagen, Denmark. Hista-
mine phosphate, carbachol, and atropine were obtained from Sigma Chemical
Co ., St . Louis, Mo. Metiamidewas the generous giftofDr.W . R . Brimblecombe
of Smith, Klein and French Laboratories, Welwyn Garden City, England .
Dextrostix were obtained from Ames Co ., Division Miles Laboratories, Inc.,
Elkhart, Ind .
Gastric Acid Secretion Measurements
Male (290-310 g) rats of the Sprague-Dawley strain were fasted for 18-24 h
inwire cages with free access to water; theywere anesthetized by an intramuscular
injectionof0.5-0.7 ml/ 100 g body weight ofa25% urethane solution . Continuous
recording ofacid secretion was performed by the method of Ghosh and Schild
(11). Briefly, the lumen of the stomach was perfused by a dilute solution of
NaOH (2.5 x 10' N) at a constant rate of I ml/min, driven by a peristaltic
pump. The emerging fluid was passed over a combination pH electrode located
15 cm below the stomach level to avoid gastric distention. The pH was recorded
graphically. Total dead space occupied by the tube leaving the stomach and the
chamber containing the electrode was 1.4 ml. Variations in the perfusate volume
were negligible. This method produces good quantitative results in the assay of
inhibitors of gastric acid secretion (10) and also gives excellent qualitative
information even in those cases in which its range of linearity (pH 7.5-1.5) is
exceeded . All injections of single doses of secretagogues and EGF were given
intravenously (i.v .) in 0.1-0 .3 ml ofphysiological saline . For continuous infusion,
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was routinely recorded through a catheter in the carotid artery. This record
showed that the variations in pressure elicited by some ofthe secretagogues had
no significance in relation to the acid secretion process in our experimental
conditions.
Hypoglycemia was produced by a single dose of insulin administered i.v.
Glycemia levels were determined by the Dextrostix semiquantitative method.
Some ofthe experiments were carried out after ligation ofthe renal vessels; this
did not produce differences relevant to our results.
Electron Microscopy
The stomach was fixed in 3% glutaraldehyde in 0.2 M sodium cacodylate
buffer, pH 7.2, containing 0.3 M sucrose, postfixed in 1% osmium tetroxide,
block-stainedwith uranylacetateand embedded inEpon. Sectionswereexamined
after staining with uranyl acetate and lead citrate.
To provide quantitative support for some of the observations, parietal cells
were photographed at x 5,000 and the negatives projected with a photographic
enlarger at x 15,000. The outline of the cell and of the areas occupied by
tubulovesicular system were traced on paper and subsequently cut out and
weighed in a precision scale.
RESULTS
Effect of EGF on Gastric Acid Secretion
EGF inhibits gastric acid secretion elicited in three different
manners: by single intravenous doses of histamine, carbachol,
or pentagastrin, by insulin-induced hypoglycemia, and by a
continuous infusion of histamine.
Aftersingle i.v.dosesofeither histamine (300 tug), carbachol
(1 jig), or pentagastrin (10 jig) are administered to anesthetized
rats, acorresponding stimulatory effect on acid secretion begins
to be detected in 2-6 min, reachesamaximallevelof-0.5 peq/
min for carbachol and histamine, and -2 tueq/min for penta-
gastrin, andfinally returnsto itsbasallevelafterperiodswhich
vary according to the drug employed. Those responses are
abolished by one single i.v. dose of EGF (10 tug) injected
shortly before the application ofthe secretagogue; the respon-
siveness to new injections of these compounds is recovered
after 60 min (Fig. 1 a and b).
The highestlevels ofacid secretionwere obtained by insulin-
inducedhypoglycemia (Fig. 2a). The stimulatory effect begins
to appear at glycemia values of 0.45-0.25 mg/ml, and is
preceded by a lag time of 30-40 min. This effect is blocked
by atropine and vagalnerve section but not by metiamide (not
shown), indicating a participation of muscarinic receptors for
acetylcholine and a probable postsynaptic liberation of this
r
60
neurotransmitter by vagal stimulus. The sharp decrease of the
perfusion liquid pH is changed abruptly by the administration
of EGF (10 tug) and the basal level of secretion is restored by
a second injection (5 tug) ofthe hormone (Fig. 2b).
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FIGURE 2
￿
Inhibitory effect of EGF on gastric acid secretion stimu-
lated by insulin-induced hypoglycemia; pH recording of gastric
lumen perfusate. (a) Stimulatory effect produced by a rapid i.v.
injection of insulin (1 .5 U) . Initial glycemia was -1 .3 mg/ml. The
glycemia at the lowest point of the curve was -0.25 mg/ml, and
acid output 24geq/min. (b) Treatmentas in a, but EGFwas injected
i.v. (10 jug) 35 min after insulin administration; an additional 5 hg
were injected i .v. at the point indicated by the arrow. The glycemia
was similar to that in a and was not altered by EGF.
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FIGURE 3
￿
Inhibitory effect of EGF on gastric acid secretion stimu-
lated by acontinuous infusion of histamine. pH recording of gastric
lumen perfusate. At the point indicated, histamine (25 jig/min) was
infused i.v. at a rate volume of 50 pl/min and maintained for the
duration of the experiment. EGF (10 jig) was given i.v. once the
stimulation of acid secretion was maximal for this rat (1 Iteq/min).
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FIGURE 1
￿
Gastric acid secretion detected by pH variations of the lumen perfusate. Inhibitory effect of EGF on the responses
induced by single doses of secretagogues. (a) Carbachol (1 Itg), histamine (300 Wg) and EGF (101tg) were injected i.v. EGF practically
eliminated the response to carbachol and histamine injected 2 and 25 min later, respectively. A new dose of carbachol given 60
min after EGF was as effective as the first one in stimulating acid secretion, whereas 2 h after EGF, histamine evoked only 57% of
its initial response. (b) Pentagastrin (p-gastrin) (10jig) and EGF (10jig) were injected i.v. as shown. The response to p-gastrin was
90% inhibited by EGF given 6 min before the secretagogue. The inhibitory action was finished 70 min later.
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￿
Parietal cell from a gastric mucosa stimulated by insulin-induced hypoglycemia ; can, intracellular canaliculus . Bar, 1
jLm . x 17,500 .
The time-course ofEGF inhibitory effect is seen more clearly
in rats that are maintained at a plateau level of acid secretion
by a continuous i.v . infusion of histamine . In the experiment
of Fig . 3, acid secretion was stabilized by this procedure at a
rate of 1 lteq/min . This effect is mediated by histamine H2
receptors, as demonstrated by its complete inhibiton by me-
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tiamide, a specific HZ receptor antagonist (2) . As shown in Fig.
3, the inhibitory effect of EGF is detected after 5 min, begins
to decline at~30 min, and has an overall duration of ^-70 min .
Even though variations were observed in the maximal levels of
acid secretion elicited by histamine, the magnitude of the
inhibition produced by EGF did not vary accordingly .FIGURE 5
￿
Parietal cell from a mucosa stimulated by insulin-induced hypoglycemia and treated with EGF in the sequence indicated
in Fig . 2 b. In the lumina of the canalicular profiles, a finely granular material of undetermined nature is seen . can, Intracellular
canaliculus ; tvs, tubulovesicular system . Bar, 1 Wm . x 11,800 .
Effect of EGF on Parietal Cell Morphology
Insulin administration proved to be an extremely effective
manner of obtaining parietal cells with images characteristic of
active secretion . Fig. 4 shows a cell taken from a mucosa whose
acid secretion curve is illustrated in Fig. 2 a . The branched and
tortuous intracellular canaliculus penetrates to all portions of
the cell. The canalicular wall is folded into abundant villous
processes that occupy the lumen . The cytoplasm is filled mainly
with densely packed mitochondria, with very few membranous
elements belonging to the tubulovesicular system. The admin-
istration ofEGF generates a completely different picture (Fig.
5) . The great majority of the parietal cells exhibit an image
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cytoplasm occupied by closely packed tubulovesicular ele-
ments, and comparatively smooth intracellular canalicuh pro-
vided with scanty villous processes. We frequently found cells
whose canalicular walls appeared smooth to an extent seen
only exceptionally in the stomach of the fasting rat . Even
though some cells showed an image more typical of the non-
secreting state than others, the overall appearance was not at
all uncertain, and a simple inspection of the sections at x
10,000-15,000 was enough to determine whether the animal
had received only insulin or insulin followed by EGF.
Quantitative support for these observations was obtained by
taking advantage of the well-known fact that the non-secreting
parietal cell has a large amount of tubulovesicular system that
occupies well-defined zones of the intracellular compartment.
Parietal cells identified at low magnification were chosen at
random, with the only condition that at least one of the
diameters of the profile be >10 gm, so as to avoid grazing
sections through one of the cell poles. 38 cells obtained from
three randomly chosen insulin-plus-EGF-treated blocks were
compared with an equal number of cells obtained from three
TABLE I
Effect of EGF on Tubulovesicular System Area in Rat
Parietal Cells
Condition
Insulin-treated 2,535 66
￿
2.6
Insulin + EGF-
￿
2,952
￿
318
￿
10.8
treated
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randomly chosen insulin-treated blocks. Total cell section areas
and the corresponding tubulovesicular system areas were de-
termined as described under Materials and Methods. The
results are shown in Table I. It is seen that the treatment with
EGF has brought about a fourfold increase in the area of cell
section occupied by tubulovesicular system .
The cortex of the canalicular wall in the insulin-treated
stomachs exhibits a finely granular texture, and shows fila-
ments of the 6- to 8-nm variety, most of which are randomly
oriented; some of them, however, form small straight bundles .
The processes that fill the canalicular lumen contain abundant
straight microfilaments oriented along their longitudinal axes
(Fig. 6b) . In their most frequent disposition, these filaments
tend to become arranged in a single plane (Fig . 6a) underlying
the plasma membrane ; they are interconnected by a fuzzy
material of moderate electron density that is also occasionally
seen between the filaments and themembrane . In some cases,
however, the filaments seem to be uniformly distributed within
the process; only very exceptionally do they appear to integrate
into a central core bundle within a villus. A comparison of
these images with those of stomachs whose secretion has been
elicited by refeeding instead of insulin administration reveals
no significant differences .
In stomachs treated with insulin followed by EGF, the
number of processes is greatly diminished so that relatively
long stretches of smooth canalicular wall can be observed . The
cortex presents tightly packed granular and filamentous ele-
ments, the latter occasionally being arranged in bundles that
course parallel to the canalicular surface . The shorter processes,
which are typical of quiescent canaliculi, do not show any form
of subplasmalemmal arrangement of the filaments, which in-
stead tend to form a loose bundle (Fig . 7).
The matrix between the tubulovesicular elements presents a
different aspect inthose places that are nearer to the canalicular
FIGURE 6
￿
Sections through canalicular wall in two parietal cells after treatment with insulin . Transverse and longitudinal sections
of processes that illustrate the arrangement of microfilaments (arrowheads) are shown . Bars, 0.1 u . x 120,000 .
Tubulovesicular
Total tubulo- system area per
Total cell vesicular system 1001Lm2 cell
area area area
ILm 2 Jim
2wall, in comparison with those that are far removed from it . In
the neighborhood of the canaliculus, the membranous elements
are separated by a dense granular matrix, whereas in other
places only an extremely thin translucent space without any
discernible structure is apparent. As reported in other studies
on oxyntic cells, no microfilaments can be demonstrated be-
tween the tubular cytomembrane elements (26) .
DISCUSSION
Our results confirm previous reports on the effect of EGF on
gastric acid secretion (4, 12) . Furthermore, they show that at
the doses employed the initiation ofits action is very rapid and
that the effect is maintained for periods ranging from 40 min
to 1 h . The possibility that EGF might act through the stimu-
lation of the secretion of gastric inhibitory polypeptide (21),
the only other known agent that exhibits somewhat comparable
properties, is ruled out by the persistence of the effect ofEGF
after excision of the entire intestine (22) . Thus, a direct inter-
action between parietal cells and EGF seems most likely.
Cultured cells that respond in some way to EGF are able to
bind it specifically at their surface (7) ; the hormone is subse-
quently internalized and finally degraded in the lysosomes (6,
7) . The possibility that a similar sequence may occur in rat
parietal cells is strengthened by the finding of receptors for
EGF on the surface of a wide variety of fibroblastic (6, 9, 23)
and epithelioid (8, 9) cells and in membrane fractions from
tissues of several species including the rat (19) .
Parietal cells are known to possess receptors for histamine,
gastrin, and acetylcholine (24). The intracellular biochemical
signals that mediate the response to the last two secretagogues
are thought to be different from the one intervening in the
histamine effect, which is known to be cyclic AMP (24). The
fact thatEGF is an effective inhibitor ofthe secretion induced
by all three of these substances renders direct competition for
receptors unsatisfactory as an explanation of the action ob-
served . We cannot rule out, however, that alterations in mem-
brane properties induced by the hormone could determine the
removal, masking, or inactivation ofall the secretagogue recep-
tors ofthe cell .
Parietal cells possess quite distinct configurations according
to their secretory state (17, 28). Resting cells show relatively
smooth intracellular canaliculi and a large amount of peculiar
apical cytomembranes known as the tubulovesicular system.
When cells are actively secreting, the intracellular canaliculi
become extensively developed and present a highly irregular
surface covered with cytoplasmic processes; at the same time,
the tubulovesicular system diminishes to the point of disap-
pearance . Advantage was taken of this structural change to
obtain a quantitative estimation of the effect of EGF on the
morphology of the insulin-stimulated parietal cell . The fourfold
increase of the tubulovesicular system area corresponds very
well with the qualitative impression that the majority ofparietal
cells in the EGF-treated stomachs are in the nonsecreting state .
The general aspect of a stomach treated with insulin followed
by EGF was entirely comparable to the stomach of a fasting
FIGURE 7
￿
Sections through canalicular wall in two parietal cells after treatment with insulin followed by EGF . Canalicular cortex,
processes, and arrangement of microfilaments are demonstrated . can, Intracellular canaliculus ; tvs, tubulovesicular system ; mfb,
microfilament bundle . Bars, 0.1 gm . x 120,000.
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113rat, except for the relatively high incidence of cells whose
canaliculi showed extremely smooth contours.
The results reported show that the administration of EGF to
stomachs stimulated by insulin-induced hypoglycemia resulted
in a reorganization of the secretory poles of parietal cells
involving its two most prominent components, namely the
cytomembranes and the microfilaments. It has been proposed
that theelaboration ofthecanalicular membrane during secre-
tion, which entails a considerable increase in area, is carried
out throughincorporation of tubulovesicularmembrane to the
secretory surface. There is also evidence indicating that the
changes in apical surface topography and the translocation of
cytomembranes are expressions of the motility of these cells
that are probably mediated by cytoskeletal elements (26). The
presence ofactin and myosin has been demonstrated biochem-
ically in oxyntic cells (18, 27). Actin filaments are associated
with the plasma membrane at the secretory pole in a highly
distinctive pattern, but they are not associated with the mem-
branes ofthetubulovesicularsystem (26). Finally, cytochalasin
B, known to interferewith cytoskeletal action, inhibits both the
passage to a secretory configuration and the secretion of HCI
(3).
After the administration of the secretagogues employed,
EGF prevented the development of the ruffled surface char-
acteristic ofthesecretory stateor forced its reversal in thecases
in which it had become established. Because the different
chains of events set in motion by these secretory stimuli must
finally converge on the mechanism that generates the topol-
ogical changes, it is reasonable to believe that the action of
EGF on surface configuration and cytomembrane transloca-
tion may be exerted through interference with cytoskeletal
function. Such a possibility is rendered more likely by the
results reported by Chinkers et al. (8) on the early action of
EFG on the morphology of cultured human carcinoma cells.
These authors showed that when these cells are exposed to
EGF, rapid and transientruffling activity is first produced and
is followed within 1 h by an extraordinary smoothing of the
cell surface. The time-course of these morphological changes
is in good agreement with our observations on the effect of
EGF on acid secretion. The results reported here differ from
others reported for EGF (5, 8, 14) in one important aspect,
namely that the contact with the hormone presumably takes
place at thebasal aspect of thecell,whereasthe recorded effect
is seen at the transcellular secretory pole.
EGF, a hormonethat elicits avariety of functional responses
(7) is present in the plasma and in several tissue extracts from
normal human subjects (15, 25). Our results, taken together
with the other reported effects of EGF involving different
manifestations of cellular motility (1, 5, 8, 14), indicate that the
action of this hormone may be concerned with the regulation
of cytoskeletal function and/or with therelation of cytoskeletal
elements and the plasma membrane at different sites. This
hormonal action may be completely unrelated to the action of
EGF on DNA synthesis, this last effect beingknown to exhibit
a dissimilar time-course (16); however, because drugs that
disrupt the cytoskeleton enhance the stimulatory effect of
growth factors on DNA replication (20), EGF action on the
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cytoskeleton might turn out to be one step in a sequence of
events leading to hormonal regulation of mitogenesis.
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